Is 1% lignocaine drug similar to 2% lignocaine when used in airway anaesthesia in a routine bronchoscopy procedure?
Phase 3
- Conditions
- Health Condition 1: J00-J99- Diseases of the respiratory system
- Registration Number
- CTRI/2020/04/024796
- Lead Sponsor
- Dr Prince James
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Consecutive patients undergoing flexible bronchoscopy during study period will be considered
eligible for inclusion if they are
1.Aged above 18 years
2.Hemodynamically stable(defined systolic B.P >100mmHg, <180mmHg)
Exclusion Criteria
1.Failure to provide informed consent
2.Documented history of lignocaine toxicity
3.Pregnancy
4.Patients undergoing TBNA and other interventions
5.Wherein bronchoscopy was performed through endotracheal or tracheostomy tube
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the cough scores during the procedure between two study groups that is 1% lignocaine and 2% lignocaine by using VAS score(0-100mm)Timepoint: 1.Immediately after procedure- Cough score as assessed by bronchoscopist,respiratory therapist and staff nurse assisting the procedure <br/ ><br>2.Two hours after procedure-cough score as assessed by patient
- Secondary Outcome Measures
Name Time Method To determine overall complication rate in number while undergoing bronchoscopy procedures in 1% vs 2% lignocaineTimepoint: immediately after the procedure;To determine overall feel of scopy as assessed by patient based on FACES pain scale scoreTimepoint: within 2 hours of procedure;To determine overall feel of scopy for the operator based on VAS score(0-100mm scale)Timepoint: immediately after the procedure;To determine total dose of lignocaine (in mg) used while performing procedure for 1% vs 2% concentrationsTimepoint: immediately after the procedure